SABBY 13G ATNM 4.18.19

Company

Actinium Pharmaceuticals, Inc.

Filed

April 18, 2019

Accession Number

0001535610-19-000080

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →